{
    "Trade/Device Name(s)": [
        "xTAGTM Respiratory Viral Panel",
        "xTAGTM RVP"
    ],
    "Submitter Information": "Luminex Molecular Diagnostics Inc.",
    "510(k) Number": "k081483",
    "Predicate Device Reference 510(k) Number(s)": [
        "k063765"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OEM",
        "OEP"
    ],
    "Summary Letter Date": "May 27, 2008",
    "Summary Letter Received Date": "May 28, 2008",
    "Submission Date": "June 23, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A",
        "Influenza A subtype H1",
        "Influenza A subtype H3",
        "Influenza B",
        "Respiratory Syncytial Virus subtype A",
        "Respiratory Syncytial Virus subtype B",
        "Parainfluenza 1",
        "Parainfluenza 2",
        "Parainfluenza 3",
        "Human Metapneumovirus",
        "Rhinovirus",
        "Adenovirus"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swabs"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "xTAGTM Data Analysis Software (TDAS RVP-I)"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex PCR",
        "Target specific primer extension"
    ],
    "Methodologies": [
        "Multiplex nucleic acid amplification",
        "Qualitative detection",
        "Primer extension"
    ],
    "Submission Type(s)": [
        "Panel",
        "Assay",
        "Software",
        "Reagent",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for xTAGTM Respiratory Viral Panel, a multiplex nucleic acid assay for simultaneous qualitative detection of multiple respiratory viruses in nasopharyngeal swabs",
    "Indications for Use Summary": "Intended for simultaneous qualitative detection and identification of multiple respiratory viral nucleic acids in nasopharyngeal swabs from individuals suspected of respiratory tract infections, to aid in diagnosis when used with clinical and laboratory findings",
    "fda_folder": "Microbiology"
}